Integrated and Iterative Automated Processes to enable Hit Discovery for the Future

Session Chair(s)

• 

  Louis Scampavia, PhD

  DIrector of HTS Chemistry and Technologies
  Scripps Florida; Department of Molecular Therapeutics, Florida, United States

Presentations:

• 10:00 AM – 10:30 AM

  HT mass spectrometry based screening of in-vitro models and translation to/from clinical and epidemiological studies
  

  Thomas Hankemeier, PhD – LACDR
• 10:30 AM – 11:00 AM

  AI Enhanced Collaborative V+R Drug Discovery
  

  Guy Oshiro, PhD – Dassault Systemes
• 11:00 AM – 11:30 AM

  Lead discovery under one (new) roof - a roadmap to a holistic LD assay value chain
  

  Roman Affentranger, PhD – Roche